Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Oncology Ventures is a venture capital firm based in the United States, founded by Ben Freeberg, a cancer survivor. The firm focuses on investing in healthcare data companies that address critical issues in cancer care. With a portfolio of 7 companies, Oncology Ventures aims to enhance early detection and improve the overall infrastructure of cancer treatment.
This firm targets technologies that improve various aspects of cancer care, including early detection, patient navigation, data access, and AI-powered treatment optimization. Oncology Ventures invests in healthcare data companies that can help mitigate the fragmented and costly nature of the U.S. oncology system.
Notable portfolio companies include mPATH, which improves access to lung cancer screenings; Tono, assisting patients in managing side effects; Risa, enhancing operational efficiency in cancer centers; Lumonus, reducing errors in radiation oncology; OncoveryCare, providing mental health support; Concr, utilizing AI for better patient outcomes; and SpotDoc, aiding in early melanoma detection.
Submit your pitch through their form at oncology.ventures.
Oncology Ventures typically participates in early-stage funding rounds, often leading investments in their focus areas.
The firm is open to follow-on investments, particularly in companies that demonstrate significant progress and alignment with their mission in cancer care.
Specific fund size details are not publicly available, but the firm maintains a focused portfolio of 7 companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.